Avanir Pharmaceuticals Inc
Equities
US05348P4019
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2014 | Otsuka : Japan's Otsuka to buy Avanir for $3.5 billion ahead of patent cliff | RE |
2014 | NASDAQ OMX : names 14 stocks to test lower fee and rebate programme | RE |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 12TCr | |
+17.75% | 11TCr | |
+17.23% | 2.59TCr | |
-24.11% | 1.93TCr | |
-18.56% | 1.62TCr | |
-18.47% | 1.56TCr | |
-47.75% | 1.46TCr | |
+57.35% | 1.43TCr | |
+5.62% | 1.4TCr |
- Stock Market
- Equities
- Stock
- News Avanir Pharmaceuticals Inc
- Avanir Pharmaceuticals : to Participate in Two Conferences in December